Calcidin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcidin

Calcidin is a specialized fixed-dose combination pharmaceutical preparation designed as a nutritional agent to provide essential minerals and vitamins. Pharmacologically, it is classified as a Mineral supplement and Vitamin supplement, playing a role as an Antihypocalcemic agent and Bone metabolism regulator. Its general purpose is supporting nutritional adequacy, often for adults and adolescents, the typical target audience for such formulations.


Quick Facts

Property Description
Active ingredients Calcium Carbonate, Calcium Hydrogen Phosphate, Calcium Lactate, Colecalciferol (Vitamin D3), Ascorbic Acid (Vitamin C)
Form Solid Oral Form (Tablet/Capsule)
Pharmacological Class Nutritional Agent, Bone Metabolism Regulator
General Purpose Nutritional support and Deficiency prevention
Origin Synthetic/Derived

Understanding the Formulation and Purpose

Calcidin is designed as a combination product for systemic administration via the oral route. The active core combines multiple mineral salts, including Calcium Carbonate and Calcium Lactate, to provide necessary Elemental Calcium, along with essential cofactors. The inclusion of Colecalciferol (Vitamin D3) is crucial for promoting active Intestinal calcium absorption. This formulation strategy is clinically recognized for maximizing the effectiveness of calcium supplementation, supporting the maintenance of necessary mineral levels.

Furthermore, the inclusion of Ascorbic Acid (Vitamin C) provides support for collagen synthesis and offers antioxidant protection for tissues. This specific composition offers a differentiating feature by combining three distinct calcium sources, which may cater to varied absorption kinetics compared to formulations utilizing only one salt. The general purpose of Calcidin is centered on aiding the maintenance of Calcium homeostasis and facilitating optimal bone Mineralization, which is critical for long-term skeletal health. The product is typically used in scenarios where dietary intake alone may be insufficient to meet the body's mineral and vitamin requirements.

Regulatory References

  1. MedlinePlus Vitamin C/Ascorbic Acid

What side effects are possible with Calcidin?

Possible Side Effects and Safety Information

The safety profile of Calcidin, a combination of calcium salts, Colecalciferol (Vitamin D3), and Ascorbic Acid, is defined by adverse reactions classified by frequency and affected organ systems, according to government regulatory documentation.


Adverse Reaction Scope

The most frequently documented adverse reactions are associated with Gastrointestinal disorders. These are typically classified as Common and may include effects such as constipation, flatulence, nausea, and abdominal pain. Less common reactions may appear in the Skin and Subcutaneous Tissue disorders as pruritus or rash.


Serious Adverse Reactions and Systemic Risks

The most clinically significant safety element involves Metabolism and Nutrition disorders. Reactions classified as Uncommon include hypercalcaemia (high blood calcium) and hypercalciuria (high urine calcium). These systemic imbalances can lead to serious adverse reactions, specifically nephrolithiasis (kidney stone formation). The rare condition known as Milk-Alkali Syndrome is also documented as a risk associated with chronic, high-dose exposure.


Safety Restrictions and Context

Regulatory safety information imposes strict limitations on the use of Calcidin. It is contraindicated in patients with pre-existing conditions that cause hypercalcaemia or hypercalciuria, as well as in those with severe renal impairment (kidney failure). The product is also restricted for individuals with Hypervitaminosis D. Consistent with exposure-related safety patterns, long-term treatment necessitates mandatory monitoring of serum calcium levels, urinary calcium excretion, and kidney function, as required by official product labels.

Overdose and Emergency Response

Overdose and When to Seek Help

Official Overdose Manifestations

Overdose, which can result from acute or chronic excessive intake, is defined by Hypercalcemia (abnormally high blood calcium) and Hypervitaminosis D. Documented clinical manifestations include Anorexia, Nausea, Vomiting, extreme Thirst (polydipsia), and frequent Urination (polyuria), alongside general Fatigue or Muscle weakness. Physiological findings requiring medical attention include elevated serum calcium levels.


Severe Outcomes and Emergency Actions

The regulatory documentation warns that severe or prolonged overdose poses a risk of Irreversible renal damage, Nephrocalcinosis, and serious Cardiac arrhythmias. Due to these systemic risks, immediate medical help is required. Individuals experiencing symptoms such as persistent increased thirst, frequent urination, nausea, and vomiting should seek immediate medical attention.


Management and Monitoring

The mandated response to an overdose involves the immediate discontinuation of all calcium and Vitamin D supplements. No specific antidote is known; therefore, treatment is supportive and symptomatic. Management includes necessary procedures like Intravenous hydration. Continuous observation is required, specifically involving the monitoring of Serum calcium levels and the Electrocardiogram (ECG) to detect and manage potential cardiac and metabolic complications. Patients with Impaired renal function are noted to have an increased risk of severe toxicity.

Therapeutic Uses of Calcidin

What Calcidin Treats: Main Uses and Benefits

Calcidin is an established therapy used for the management of certain calcium-related conditions. Its therapeutic utility is primarily associated with helping to maintain normal calcium levels in individuals diagnosed with hypocalcemia. This condition involves abnormally low levels of calcium in the blood.

Calcidin may also be used as a component of the supportive treatment regimen for patients with specific bone disorders, which include conditions characterized by inadequate mineralization. The medication is intended to support bone health and mitigate risks associated with severe calcium deficiency. By addressing these factors, Calcidin is designed to help improve patient comfort and support a return to function related to calcium and bone metabolism issues.


Quick Facts: Therapeutic Uses

  • Addresses hypocalcemia (low blood calcium).
  • Supports the maintenance of normal blood calcium levels.
  • Manages symptoms associated with specific bone mineralization disorders.
  • Intended to help improve patient comfort in calcium-deficient states.

For information regarding approved indications and usage, consult a healthcare provider. The appropriate dosage and administration must be determined by a healthcare provider.

Eligibility and Restrictions for Use

Who can and cannot use Calcidin?

Calcidin is intended for use exclusively by adults and the elderly, as its safety and effectiveness are not established for the pediatric population (children and adolescents) and use is explicitly not recommended in this age group.

The medicine is subject to several absolute contraindications based on regulatory labeling. Individuals must not use Calcidin if they have pre-existing conditions that affect mineral balance, including Hypercalcaemia (high blood calcium levels), Hypercalciuria (high urinary calcium levels), or Hypervitaminosis D (vitamin D toxicity). Use is also strictly prohibited in patients with Severe Renal Impairment or those diagnosed with kidney stones (nephrolithiasis). A known hypersensitivity to any component is also an absolute contraindication.

For certain life stages, use is restricted and requires caution. The medicine is not recommended during pregnancy. During lactation (breastfeeding), use requires caution and is subject to clinical monitoring. Patients with non-severe renal impairment must also be monitored closely for mineral levels.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Calcidin

Interaction scope

Category Official Regulatory Finding
Medicinal product categories with documented interactions Vitamin D analogues, Cardiac Glycosides, Thiazide Diuretics, Glucocorticoids, Tetracycline and Quinolone Antibiotics, Bisphosphonates, Thyroid Hormones, and Hepatic Enzyme Inducers.
Specific interacting medicines (if explicitly listed) Calcitriol, Phenytoin, Barbiturates, and Thyroxine.
Mechanistic basis of interactions (only if stated in label) Pharmacokinetic interactions involve chelation reducing other drug absorption and metabolic inactivation (e.g., Vitamin D3). Pharmacodynamic interactions include reduced renal calcium excretion.
Timing-based interaction rules (if applicable) Administration must be separated by a minimum period of four hours from agents like Tetracycline and Quinolone Antibiotics, Bisphosphonates, and Thyroxine due to reduced absorption.
Population-specific interaction notes (if applicable) Cautions are documented for patients with Sarcoidosis and those with Severe Renal Insufficiency, as well as patients receiving Cardiac Glycosides.
Interaction-related restrictions Co-administration with other high-dose Vitamin D analogues and/or calcium sources is restricted.

Interaction classifications (high-level)

Classification Official Regulatory Finding
Interaction severity classification (as defined in official documents) Avoidance Required (Vitamin D analogues); Clinically Significant Interaction/Required Separation (Chelating Agents); Caution/Monitoring Required (Diuretics and Digitalis).
Regulatory basis (EMA / FDA / etc.) Information derived from official regulatory prescribing information.
Interaction-context constraints (as defined in official documents) Conditional on co-administration timing and patient co-morbidities.

Resulting interaction structure

Official interaction statements:

  • The official profile restricts combination with Vitamin D analogues and notes the risk of cardiac toxicity with Digitalis.
  • Reduced Colecalciferol effectiveness is linked to Hepatic Enzyme Inducers.
  • The calcium component requires specific timing separation for numerous oral agents.

Connection to the overall interaction profile: Regulatory documents structure the product's interaction profile around two primary factors: the chelation activity of calcium, which governs mandatory administration separation, and the additive pharmacodynamic effect of the calcium/Vitamin D combination, which controls co-administration with other hypercalcemia-inducing agents.

Mechanism of Action

Calcitonin Receptor Agonism and Osteoclast Inactivation

Calcidin acts as an agonist of the Calcitonin Receptor (CTR), which is predominantly expressed on osteoclasts (bone-resorbing cells). Upon binding, Calcidin triggers an intracellular signaling cascade mediated by G-proteins, leading to a rapid surge in secondary messengers like cAMP. This biochemical action swiftly disorganizes the osteoclast's cytoskeleton and causes the functional ruffled border to retract. The cellular retraction results in an immediate and direct inhibition of bone resorption at the tissue level.

Modulation of Mineral Homeostasis

The resulting inhibition of bone matrix breakdown reduces the release of minerals into the blood. Furthermore, Calcidin binds to CTRs in the renal tubules, influencing ion transport to increase the urinary excretion of calcium and phosphate. The combined effects on bone and kidney contribute to the modulation of mineral homeostasis, resulting in the lowering of serum calcium concentrations (hypocalcemia).

Dosage and Administration Information

How Calcidin is Used: Administration Guidelines

Calcidin is a solid oral form preparation, and its usage is guided by specific administration rules designed to ensure the proper delivery and absorption of its Elemental Calcium and Colecalciferol (Vitamin D3) components.


Administration Protocol

Feature Usage Guideline
Route of Administration The medicine is taken via the oral route (by mouth).
Standard Dosing Principle The total daily dose of Elemental Calcium, typically 1,000 mg to 1,200 mg, and 400 IU to 1,000 IU of Colecalciferol, must be administered.
Frequency & Timing Daily administration is the standard regimen, but the total daily dose must be segmented and administered in divided doses (e.g., two to three times per day).
Intake Condition Each segmented dose must be taken with a meal to enhance the dissolution and absorption of the Calcium Carbonate component.

High-Level Usage Context

Calcidin is intended for long-term supportive therapy to maintain mineral levels, rather than for short-term use. This continuous administration pattern is essential for addressing the underlying need for nutritional adequacy.

Procedural and Population Requirements

Dose Segmentation is Required: It is noted that the body's ability to absorb elemental calcium is limited, and a single dose should not exceed 500 mg. Consequently, the daily intake must be divided to ensure maximum fractional absorption. Older adults may require the higher end of the Vitamin D3 range, for instance, 800 IU daily, as part of the regimen. If a dose is missed, it should not be doubled to compensate, maintaining the integrity of the daily dosing schedule.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Calcidin


Evidence for Use in Managing Nutritional Hypocalcemia and Deficiency

Research has examined the combination of calcium and Vitamin D components within Calcidin in interventional studies and short-term randomized trials. These studies were conducted during periods of temporary physiological imbalance in research examining patterns related to the body's mineral levels. The main goal of this research was to monitor physiological strain or stress and outcomes related to systemic or functional imbalance, specifically by measuring levels of calcium and Vitamin D (25(OH)D) in the blood of study participants.

Studies reported measurements where the combination of calcium and Vitamin D was associated with measurements related to serum 25(OH)D levels in deficient patients. Similarly, research explored the monitoring of serum calcium concentration. The evidence primarily provides context but not individual predictions, as it focuses on changes in blood chemistry, not on long-term clinical outcomes. Follow-up durations were limited in many studies, focusing on the repletion phase rather than extended years of use.


Evidence for Use in Supportive Bone Health and Mineralization

The calcium and Vitamin D combination was evaluated in research exploring outcomes related to physiological strain or stress in numerous long-term Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews. These studies were used in research exploring how functional limitations or the risk of episodic or acute changes (like fractures) evolve over time. Study outcomes examined included measures related to Bone Mineral Density (BMD) at skeletal sites, as well as the incidence of fractures.

Findings related to the monitoring of fracture outcomes were mixed across the major clinical trials. Some systematic reviews describe data patterns related to varied observations in fracture risk, especially when examining community-dwelling participants. Research highlights changes measured during the study period, but the effect appears to depend heavily on the baseline Vitamin D status and dietary habits of the specific group studied.


Evidence Gaps and Research Uncertainty

Evidence highlights what is known — and what is still uncertain — regarding Calcidin's research base. One of the main research limitation frames is the heterogeneity (differences) in results across the major RCTs concerning fracture outcomes. This means that certainty remains low regarding a consistent, universal finding for all patients. While research provides context, studies suggest it does not determine whether an individual will respond similarly, and these findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Calcidin (FAQ)


Q: Is it normal to experience mild constipation or bloating when first starting Calcidin?

Official product safety documentation indicates that common side effects associated with Calcidin are related to the digestive system. These frequently observed effects include constipation and flatulence (bloating or gas). Constipation and flatulence are recognized and listed in the official safety profile.


Q: Are there any common over-the-counter medications that interact negatively with Calcidin?

Regulatory documents caution that the calcium component of Calcidin can reduce the absorption of other oral medicines through a process called chelation. This risk applies to various interacting medication categories. It is generally advised to review the official interaction categories to determine if any over-the-counter medicines may be affected.


Q: Does Calcidin affect the way certain antibiotics (like tetracyclines) are absorbed?

Official product information confirms that the calcium in Calcidin can reduce the absorption of certain antibiotics, specifically Tetracycline and Quinolone classes. Official regulatory guidelines state that the administration of Calcidin and these antibiotics must be separated by a minimum of four hours.


Q: Can Calcidin be taken alongside thyroid replacement medicines like Levothyroxine?

The official interaction profile lists Thyroid Hormones as interacting agents. The regulatory documents require that the administration of Calcidin and your thyroid medicine be separated by a minimum of four hours to avoid reduced absorption of the thyroid medicine.


Q: Is there a best time of day (morning or night) to take Calcidin for maximum absorption?

The total daily dose must be segmented and taken with a meal to enhance the absorption of the calcium component. The guidance emphasizes taking each segmented dose with a meal to enhance absorption, but official administration guidelines do not specify a superior time of day (morning versus evening).


Q: Why is it important to separate the dose of Calcidin from some other medications?

The required separation is due to the calcium component's chemical action, known as chelation. This process can bind to other drugs in the digestive system, which reduces the amount of the other medicine the body absorbs. The separation is necessary to help maximize the absorption and intended effectiveness of the co-administered drugs.


Q: What happens if I occasionally forget to take my dose of Calcidin?

Regulatory administration guidelines explicitly instruct that a missed dose must not be doubled to compensate for the one you forgot. Regulatory guidelines note that the standard dosing schedule should be maintained.


Q: Has there been research done on Calcidin's effectiveness for bone loss prevention?

The combination of calcium and Vitamin D in Calcidin has been studied in long-term clinical trials. These studies explored outcomes related to bone health, including measurements of Bone Mineral Density (BMD) and the incidence of fractures, which are factors in bone loss prevention.


Q: Do other vitamin supplements (e.g., iron, zinc) interact with Calcidin?

Official interaction guidance notes that the calcium component is a chelating agent and cautions against co-administration with other high-dose calcium sources. Because the underlying mechanism involves chelation, similar cautions may apply to other mineral supplements, like iron and zinc, that interact in the same way.


Q: How does Calcidin specifically help in the management of hypoparathyroidism?

Calcidin is classified as an Antihypocalcemic agent, meaning it helps to counteract low levels of calcium in the blood (hypocalcemia). Official regulatory documents for similar combination products often cite their use in managing hypocalcemia, which includes cases associated with hypoparathyroidism.


Q: Why do some people say Calcidin can be used as an antacid?

One of the active ingredients in Calcidin is Calcium Carbonate. This specific compound is widely recognized in its chemical purpose and is used in other over-the-counter products as an antacid. However, Calcidin's official regulatory purpose is defined as a nutritional agent and bone metabolism regulator.


Q: Can Calcidin help improve low Vitamin D levels in the blood?

The combination product includes Colecalciferol (Vitamin D3), which is essential for mineral balance. Studies measured the impact on serum Vitamin D levels in deficient patients, supporting its role in addressing Vitamin D status.


Q: What is the recommended daily intake of elemental calcium that Calcidin aims to supplement?

The dosage information for Calcidin provides the total daily elemental calcium intake in the range of 1,000 mg to 1,200 mg. This amount is structured to help meet or supplement the Recommended Dietary Allowance (RDA) of elemental calcium for the typical adult target population.


Q: Why do some people feel thirsty or need to urinate more when taking calcium supplements?

The official safety profile lists the uncommon but serious adverse reactions of hypercalcaemia (high blood calcium) and hypercalciuria (high urine calcium). These systemic imbalances are known to be associated with symptoms such as increased thirst and the need to urinate more frequently.

How should Calcidin be stored and disposed of?

How to Store and Dispose of Calcidin

Calcidin (Calcium Carbonate USP, etc.) must be stored at Controlled Room Temperature, typically ranging from 15 C to 30 C (59 F to 86 F). The product must be protected from moisture and should not be frozen.

Storage Requirements

Requirement Status
Temperature Controlled Room Temperature
Container Store in original container; keep tightly closed
Protection Protect from moisture and freezing
Child Safety Keep out of the reach of children

Disposal

Unused or expired Calcidin must not be disposed of in household trash or poured down the sink or toilet. Disposal should follow local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Calcidin found in:

A-Z Index: